QuidelOrtho (QDEL) stock is in focus as the company weighs selling its point-of-care testing unit for ~$1.5B to cut debt.
Omega Laboratories, Inc. ("Omega"), and Cannabix Technologies Inc. ("Cannabix") (CSE: BLO) (OTCID: BLOZF) announce the development and validation of a DOT-like drug-test panel for breath testing. The ...
Diagnostics firm QuidelOrtho Corp is looking to sell its point-of-care testing unit at a valuation of $1.5 billion, the ...
Build what differentiates you. Buy what doesn't. Your product is your business. Your testing infrastructure is not.
Trump told Zelenskyy at the NATO summit that Ukraine would get the right to manufacture Patriot air defence systems. The move ...
Factionalism has long plagued the Haryana Congress, with successive general secretaries incharge of Haryana failing to bring ...
A US startup’s demonstration reactor has reached initial criticality in just 150 days, hence ...
The Government will oppose a [url=https://www.irishexaminer.com/maintopics/sinn-f%C3%A9in_topic-5071388.html]Sinn Féin[/url] ...
NATO leaders meet as Trump’s demands test alliance unity and future security commitments.
Expanded breath-testing capability enables recent-use detection across a panel modeled after the DOT federally mandated urine drug test panel.
The ISVs add speed and stealth for cavalry scouts and dismounted infantrymen who operate at or beyond the front lines.